KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 74 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $224 | -5.5% | 23,250 | -11.6% | 0.01% | +10.0% |
Q2 2023 | $237 | +5.8% | 26,290 | -7.8% | 0.01% | -9.1% |
Q1 2023 | $224 | -99.9% | 28,510 | +135.3% | 0.01% | -83.3% |
Q4 2020 | $230,000 | +28.5% | 12,119 | -14.8% | 0.07% | +15.8% |
Q3 2020 | $179,000 | +32.6% | 14,219 | +27.8% | 0.06% | +23.9% |
Q2 2020 | $135,000 | -6.2% | 11,129 | -40.9% | 0.05% | -24.6% |
Q1 2020 | $144,000 | -42.2% | 18,829 | +34.8% | 0.06% | -17.6% |
Q4 2019 | $249,000 | -25.2% | 13,969 | -51.4% | 0.07% | -40.3% |
Q3 2019 | $333,000 | -39.0% | 28,736 | +16.5% | 0.12% | -38.6% |
Q2 2019 | $546,000 | +14.9% | 24,667 | +48.7% | 0.20% | -25.5% |
Q1 2019 | $475,000 | +24.3% | 16,591 | -14.2% | 0.27% | +153.3% |
Q4 2018 | $382,000 | – | 19,341 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |